The Farber Center has become the 34th in the world and the first in NYC to treat patients with AccuBoost, a new image-guided treatment for breast cancer. The process uses digital mammography for localization and surface applications for the delivery of radiation. AccuBoost is the first technology to allow High Dose Rate (HDR) treatment of breast cancer in a Non-Invasive way.
Prior to AccuBoost, partial breast irradiation treatment was performed via invasive techniques such as employing multiple protruding catheters or with inflatable balloon devices implanted into the breast. AccuBoost can be delivered either prior to or after the main external beam portion of women’s treatment. The breast is immobilized and imaged in a manner similar to mammography but without excessive pressure. A special applicator is positioned to deliver the radiation with great accuracy, and virtually eliminating unwanted exposure to heart, lungs and chest wall.
Patients receive treatment each day for five to eight days, and for each treatment, the beam targets different angles so that the entire surface is radiated. The brachytherapy suite at The Farber Center for Radiation Oncology has the AccuBoost digital mammography unit available to facilitate the delivery of this new treatment technique.
The advantages of AccuBoost
According to the Accuboost Web site, the tried-and-true mainstream practice of whole breast irradiation following lumpectomy has an excellent record that spans more than three decades. The WBI procedure includes an all-important “boost” phase. The AccuBoost system is designed to target the boost dose scientifically and accurately with good quality control. The anticipated benefits of AccuBoost are listed below:
Noninvasive radiation delivery in a simple outpatient procedure.
Accurate targeting of the radiation to the intended site via real-time image guidance.
Conformal radiation field — matches the target size, shape and location.
Minimal dose to healthy tissue as the radiation is focused on the intended target, sparing exposure to the heart, lungs and the uninvolved breast.
Uniform radiation field from the center to the edge.
Homogenous treatment — no hot or cold spots in the field.
Excellent reliability, reproducibility and process control.
Digital map of the boost dose for in-process correction and for future reference.






